Does Cardiac Rehabilitation Reduce the Risk of Recurrence of Atrial Fibrillation Following the First Catheter Ablation?
NCT ID: NCT03389633
Last Updated: 2018-01-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
462 participants
INTERVENTIONAL
2007-01-01
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rehabilitation of Patients With Atrial Fibrillation
NCT03035539
Evaluation of Predictive Factors for Recurrence of Persistent Atrial Fibrillation After Ablation
NCT06620575
Atrial Fibrillation, Prevention and Rehabilitation
NCT06337045
Echocardiographic Risk Factors of Stroke in Patients With Atrial Fibrillation
NCT03824509
A Study of a Lifestyle Program on Recurrent Atrial Fibrillation
NCT06155357
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Rehabilitation group
this group follows a 3 months rehab program
rehabilitation
No rehabilitation
This group does not follow a rehab program
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rehabilitation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* a prosthetic heart valve
* a severe valvulopathy,
* hyperthyroidism at the time of the ablation,
* pregnancy and breastfeeding,
* intensive sport (more than 1 hour a day),
* a myocardial infarction or a thromboembolic event within 3 months after the ablation,
* a pacemaker
* end-stage renal disease.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
prof. dr. Paul Dendale
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
prof. dr. Paul Dendale
Professor of cardiovascular pathophysiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul Dendale, prof. dr.
Role: PRINCIPAL_INVESTIGATOR
Jessa Hospital
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16.46/cardio16.08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.